^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
ESK981
i
Other names: ESK981, CEP-11981, SSR-106462, CEP11981, CEP 11981, ESK 981, ESK-981, SSR106462, SSR 106462
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Esanik Therap, Teva
Drug class:
VEGFR inhibitor, TIE inhibitor
Related drugs:
Phase 2
University of Michigan Rogel Cancer Center
Recruiting
Last update posted :
04/25/2024
Initiation :
04/19/2024
Primary completion :
04/01/2027
Completion :
04/01/2029
SYP • CHGA
|
ESK981
Share
